Prognostic Impact of <i>IGF2BP3</i> Expression in Patients with Surgically Resected Lung Adenocarcinoma
Wei Guo(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Jie He(First Affiliated Hospital of Jinan University), Huan Wan(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Qilin Huai(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 50
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415